Current perspectives on Gleason grading of prostate cancer

Current Urology Reports

Volumn 12, Issue 3, 2011, Pages 216-222

  Iczkowski, Kenneth A ^a   Lucia, M Scott ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Grading; Modified Gleason; Pattern; Prostate cancer

Indexed keywords

ABLATION THERAPY; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; DIAGNOSTIC ERROR; GLEASON SCORE; HUMAN; OUTCOME ASSESSMENT; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; TUMOR BIOPSY;

BIOPSY, NEEDLE; FROZEN SECTIONS; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 79955811711     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0181-5     Document Type: Article

References (55)

1. DF Gleason 1966 Classification of prostatic carcinomas Cancer Chemother Rep 50 125 8 5948714 1:STN:280:DyaF287ht1WgsA%3D%3D
2. DF Gleason GT Mellinger 1974 and VA Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 58 64 4813554 1:STN:280:DyaE2c7gt1Clug%3D%3D
3. KA Iczkowski D Hossain KC Torkko, et al. 2008 Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer Urology 71 1166 71 18279927 10.1016/j.urology.2007.10.013
4. MS Guimaraes MM Quintal LR Meirelles, et al. 2008 Gleason score as a predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy Int Braz J Urol 34 23 9 18341718 10.1590/S1677-55382008000100005
5. AW Partin MW Kattan EN Subong, et al. 1997 Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1445 51 9145716 10.1001/jama.277.18.1445 1:STN:280:DyaK2s3ptFWjsA%3D%3D (Pubitemid 27208886)
6. DF Gleason 1992 Histologic grading of prostate cancer: a perspective Hum Pathol 23 273 9 1555838 10.1016/0046-8177(92)90108-F 1:STN:280: DyaK383htVWjug%3D%3D
7. FD Gilliland DF Gleason WC Hunt, et al. 2001 Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993 J Urol 165 846 50 11176484 10.1016/S0022-5347(05)66542-1 1:STN:280:DC%2BD3M3jtlaqsQ%3D%3D (Pubitemid 32156293)
8. KA Iczkowski DG Bostwick 1998 The pathologist as optimist: Cancer grade deflation in prostatic needle biopsies [Editorial] Am J Surg Pathol 22 1169 70 9777978 10.1097/00000478-199810000-00001 1:STN:280:DyaK1cvkvFCjug%3D%3D (Pubitemid 28462764)
9. WC Allsbrook KA Mangold MH Johnson, et al. 2001 Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologists Hum Pathol 32 81 8 11172299 10.1053/hupa.2001.21135 (Pubitemid 32150632)
10. L Egevad 2001 Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images Urology 57 291 5 11182339 10.1016/S0090-4295(00)00922-5 1:STN:280:DC%2BD3M7psFGktg%3D%3D (Pubitemid 32140806)
11. JI Epstein 2000 Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made Am J Surg Pathol 24 477 8 10757394 10.1097/00000478-200004000-00001 1:STN:280:DC%2BD3c3hvVehsg%3D%3D (Pubitemid 30180740)
12. AR Jara-Lazaro AA Thike PH Tan 2010 Diagnostic issues in second opinion consultations in prostate pathology Pathology 42 6 14 20025474 10.3109/00313020903434330
13. A Billis F Rogerio RV Oliveira, et al. 2008 The border between low- and high grade Gleason score for prostate carcinoma: 6 or 7a (3+4)? Mod Pathol 21 149A
14. AA Patel M Chen AA Renshaw, et al. 2007 PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5 JAMA 298 1533 8 17911498 10.1001/jama.298.13.1533 1:CAS:528:DC%2BD2sXhtFeit77J (Pubitemid 47529387)
15. L Cheng DD Davidson H Lin, et al. 2007 Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy Cancer 110 1967 72 17823907 10.1002/cncr.23004 (Pubitemid 350036855)
16. DJ D'Ambrosio AL Hanlon T Al-Saleem, et al. 2007 The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 1082 7 17241749 10.1016/j.ijrobp.2006.09.050
17. JR Stark S Perner MJ Stampfer, et al. 2009 Gleason score and lethal prostate cancer: does 3+4=4+3? J Clin Oncol 27 3459 64 19433685 10.1200/JCO.2008.20.4669
18. DM Fanning E Kay Y Fan, et al. 2009 Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4+3 as high or intermediate grade BJU Int 105 631 5 19732053 10.1111/j.1464-410X.2009.08810.x
19. DJ Grignon 2004 Unusual subtypes of prostate cancer Mod Pathol 17 316 27 14976541 10.1038/modpathol.3800052 (Pubitemid 41646610)
20. BJ Bock DG Bostwick 1999 Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol 23 781 5 10403300 10.1097/00000478-199907000-00005 1:STN:280:DyaK1MzjtVSqtg%3D%3D (Pubitemid 29307683)
21. DA Brinker SR Potter JI Epstein 1999 Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression Am J Surg Pathol 23 1471 9 10584700 10.1097/00000478-199912000-00004 1:STN:280:DC%2BD3c%2FkvFeqtw%3D%3D
22. JI Epstein WC Allsbrook MB Amin, et al. 2005 The 2005 International Society of Urologic Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 1228 46 16096414 10.1097/01.pas. 0000173646.99337.b1 (Pubitemid 41232997)
23. KA Iczkowski KL Ferguson DD Grier, et al. 2003 Adenoid cystic carcinoma of the prostate: clinicopathologic findings in 19 cases Am J Surg Pathol 27 1523 9 14657711 10.1097/00000478-200312000-00004 (Pubitemid 37486613)
24. JI Epstein 2004 Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy Mod Pathol 17 292 306 10.1038/modpathol.3800050 (Pubitemid 41646609)
25. L Cheng TJ Sebo J Slezak, et al. 1998 Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy Cancer 83 2164 71 9827721 10.1002/(SICI)1097-0142(19981115)83: 10<2164::AID-CNCR15>3.0.CO;2-I 1:STN:280:DyaK1M%2FktlChsQ%3D%3D (Pubitemid 28525398)
26. DG Bostwick J Qian F Civantos, et al. 2004 Does finasteride alter the pathology of the prostate and cancer grading? Clin Prostate Cancer 2 228 35 15072606 1:CAS:528:DC%2BD2cXktlChtr8%3D (Pubitemid 38500693)
27. MS Lucia JI Epstein PJ Goodman, et al. 2007 Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial J Natl Cancer Inst 19 99 1375 83 (Pubitemid 351767184)
28. AB Barqawi CI O'Donnell VJ Siomos AH How 2010 The effect of short-term dutasteride intake in early state prostate cancer: analysis of 148 patients who underwent three-dimensional prostate mapping biopsy Urology 76 1067 71 20472268 10.1016/j.urology.2010.02.063 This study demonstrated that a 3-month course of dutasteride could decrease the amount of upgrading in Gleason scores that occurred between the initial 12-core prostate biopsy and subsequent mapping or "saturation" biopsies sampling a median of 60 tissue cores
29. WC Allsbrook KA Mangold MH Johnson, et al. 2001 Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists Hum Pathol 32 74 80 11172298 10.1053/hupa.2001.21134 (Pubitemid 32150631)
30. AM Lessells RA Burnett SR Howatson, et al. 1997 Observer variability in the histopathological reporting of needle biopsy specimens of the prostate Hum Pathol 28 646 9 9190997 10.1016/S0046-8177(97)90172-6 1:STN:280: DyaK2szjsVejsg%3D%3D (Pubitemid 27258416)
31. JD Kronz MA Silberman WC Allsbrook JI Epstein 2000 A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy Cancer 89 1818 23 11042578 10.1002/1097-0142(20001015)89:8<1818::AID-CNCR23>3.0.CO;2-J 1:STN:280:DC%2BD3M%2FjtVGhtQ%3D%3D
32. DG Bostwick 1994 Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies Am J Surg Pathol 18 796 803 8037294 10.1097/00000478-199408000-00006 1:STN:280:DyaK2czhtFCjuw%3D%3D (Pubitemid 24229402)
33. DM Steinberg J Sauvageot S Piantadosi JI Epstein 1997 Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings Am J Surg Pathol 21 566 76 9158682 10.1097/00000478- 199705000-00010 1:STN:280:DyaK2szgt1ehsw%3D%3D (Pubitemid 27213072)
34. B Djavan K Kadesky B Klopukh, et al. 1998 Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens Eur Urol 33 261 70 9555550 10.1159/000019578 1:STN:280:DyaK1c3hs1erug%3D%3D (Pubitemid 28140423)
35. V Narain FJ Bianco DJ Grignon, et al. 2001 How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival? Prostate 49 185 90 11746263 10.1002/pros.1133 1:STN:280:DC%2BD3Mnps1WmsQ%3D%3D (Pubitemid 33062615)
36. K Stav S Judith H Merald, et al. 2007 Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer? Urol Oncol 25 383 6 17826654 10.1016/j.urolonc.2006.12.013 (Pubitemid 47362756)
37. TF Hsieh CH Chang WC Chen, et al. 2005 Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer J Chin Med Assoc 68 167 71 15850066 10.1016/S1726-4901(09)70243- 6
38. SW Fine JI Epstein 2008 A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score J Urol 179 1335 8 18289601 10.1016/j.juro.2007.11.057 discussion 8-9
39. R Kvale B Moller R Wahlqvist, et al. 2009 Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study BJU Int 103 1647 54 19154461 10.1111/j.1464-410X.2008. 08255.x
40. P Kahl S Wolf A Adam, et al. 2009 Saturation biopsy improves preoperative Gleason scoring of prostate cancer Pathol Res Pract 205 259 64 19106019 10.1016/j.prp.2008.10.010
41. AA Elabbady MM Khedr 2006 Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score Eur Urol 49 49 53 16314035 10.1016/j.eururo.2005.08.013 (Pubitemid 41789953)
42. RT Divrik A Eroglu A Sahin, et al. 2007 Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens Urol Oncol 25 376 82 17826653 10.1016/j.urolonc.2006.08. 028 (Pubitemid 47362754)
43. DM Berney 2007 Low Gleason score prostatic adenocarcinomas are no longer viable entities Histopathology 50 683 90 17493232 10.1111/j.1365-2559.2007. 02596.x 1:STN:280:DC%2BD2s3osFWnsg%3D%3D (Pubitemid 46683912)
44. JC Bailar GT Mellinger DF Gleason 1966 Survival rates of patients with prostatic cancer, tumor stage, and differentiation-preliminary report Cancer Chemother Rep 50 129 36 5948715
45. JR Srigley MB Amin DG Bostwick, et al. 2000 Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee Arch Pathol Lab Med 124 1034 9 10888780 1:STN:280:DC%2BD3czptVKluw%3D%3D (Pubitemid 30602046)
46. P Zareba J Zhang A Yilmaz, et al. 2009 he impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice Histopathology 55 384 91 19817888 10.1111/j.1365-2559.2009.03405.x This study demonstrated that the application of modified Gleason grading criteria tends to lead to higher Gleason scores in both biopsy and prostatectomy specimens
47. MS Guimaraes A Billis MM Quintal, et al. 2006 The impact of the 2005 International Society of Urological Pathology (ISUP) consensus conference on standard Gleason grading of prostatic carcinoma Mod Pathol 19 139A
48. B Helpap L Egevad 2006 The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens Virchows Arch 449 622 7 17091254 10.1007/s00428-006-0310-6 (Pubitemid 44832632)
49. SG Veloso MF Lima PG Salles, et al. 2007 Interobserver agreement of Gleason score and modified Gleason score in needle biopsy and in surgical specimen of prostate cancer Int Braz J Urol 33 639 46 17980061 10.1590/S1677-55382007000500005 discussion 47-51
50. M Tsivian L Sun V Mouraviev, et al. 2009 Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy Urology 74 1090 3 19616835 10.1016/j.urology.2009.03.043
51. A Billis MS Guimares LL Freitas, et al. 2008 The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostate carcinoma in needle biopsies J Urol 180 548 53 18550106 10.1016/j.juro.2008.04.018 This study first demonstrated that revised Gleason grading of prostate biopsy specimens may have advantages over the traditional criteria with regard to association with patient outcome
52. L Egevad WC Allsbrook Jr 2005 Epstein JI: Current practice of Gleason grading among genitourinary pathologists Hum Pathol 36 5 9 15712175 10.1016/j.humpath.2004.10.001 (Pubitemid 40215627)
53. JD Kronz AA Shaikh JI Epstein 2001 Atypical cribriform lesions on prostate biopsy Am J Surg Pathol 25 147 55 11176063 10.1097/00000478-200102000- 00002 1:STN:280:DC%2BD3M7is1Okuw%3D%3D (Pubitemid 32167496)
54. M Latour MB Amin A Billis, et al. 2008 Grading of invasive cribriform carcinoma on prostate needle biopsy: An interobserver study among experts in genitourinary pathology Am J Surg Pathol 32 1532 9 18724248 10.1097/PAS. 0b013e318169e8fd This study highlights the difficulties with grading cribriform cancer (does it behave as Gleason 3, Gleason 4, or maybe Gleason 5?) and the need for definitive outcome-based studies to determine its proper grading
55. Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, et al. Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome. In press, American Journal of Clinical Pathology, 2011.